Recognition continues commitment of award-winning health content to educate and inspire
Yardley, Pa. (August 27, 2019) - StayWell, a health empowerment company, today announced it has been awarded 10 Platinum and Gold Hermes Creative Awards for outstanding creative in health and wellness, with a focus on health, wellness, and health care associations. The Hermes Creative Awards is an international competition for marketing professionals, media conglomerates, and Fortune 500 companies that are involved in the concept, writing and design of marketing communications programs and emerging technologies in print media, public relations/communications, and electronic/social/interactive media.
StayWell produces custom health engagement campaigns for health care providers, payers, and national health care associations across the U.S. Through branded and white-label materials and publications, StayWell develops educational materials to engage and inform audiences with trusted vetted medical content. Its creative design portfolio offers beneficial materials that support client outreach efforts.
Content and design from five StayWell industry publications received top honors in the 2019 Hermes Awards. Additionally, StayWell’s interactive formats, patient education, and design layout also received special recognition. StayWell develops its content and design through a robust internal content and creative design team to tailor education and industry association information to meet the needs of its audiences, in formats that are proven most accessible and engaging to its users.
"This recognition from the Hermes Creative Awards affirms our commitment to deliver award-winning, essential information and easy-to-understand content that empowers patients to take an active role in managing their health," said StayWell Co-Chief Content Officer PJ Bell. "This latest recognition from Hermes keeps us focused on creating empowering content to support clients in keeping their members informed and supporting better doctor-patient engagement to illuminate the path to better health."
StayWell’s 2019 Hermes Creative Awards winners include:
Generosity annual report (Print Media – Lehigh Valley Health Network)
Leaps & Bounds magazine (Print Media – Loma Linda University Health)
Life Happens (Print Media – Krames Patient Education)
My Blue Health magazine (Print Media – Blue Cross Complete of Michigan)
myEHP publication (Print Media – Johns Hopkins Employer Health Plan)
Connections magazine (Print Media – NorthShore University HealthSystem)
Mediterranean-Style Eating (Print Media – Krames Patient Education)
Between The Lines website design (Electronic Media – DiabetesSisters)
Healthy Connections magazine (Print Media – Summit Medical Group)
SHINE magazine (Print Media – Methodist Health System)
The Hermes Creative Awards are administered and judged by the Association of Marketing and Communication Professionals (AMCP), the industry's pre-eminent third-party evaluator of creative work. As a Platinum award winner, StayWell joins some of the world's most recognizable brands, including Aflac, Blue Cross & Blue Shield, Hilton and Pepsi.
StayWell is a health empowerment company that enables populations to improve health outcomes through the science of behavior change. For more than 40 years, the company has been a pioneer in employer well-being and patient education solutions that lower risks and reduce costs. StayWell has earned numerous top industry honors for its population health programs, including the C. Everett Koop National Health Award and the Web Health Award. The company has also received Utilization Review Accreditation Committee (URAC) and National Committee for Quality Assurance (NCQA) accreditation for several of its programs. StayWell is majority-owned by Healthcare Services & Solutions, LLC, a wholly owned subsidiary of Merck & Co., Inc. The company is headquartered in Yardley, Pa., with additional locations including St. Paul, Minn. and Portland, Ore. To learn more, visit www.staywell.com or connect with StayWell on Twitter, Facebook or LinkedIn.
For more than a century, Merck, a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer's disease and infectious diseases including HIV and Ebola. For more information, visit www.merck.com and connect with us on Twitter, Facebook, YouTube and LinkedIn.
Forward-Looking Statement of Merck & Co., Inc., Kenilworth, N.J., USA
This news release of The StayWell Company, a subsidiary of Merck & Co., Inc., Kenilworth, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forwardlooking statements. Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions. The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2018 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).
About Vestar Capital Partners
Vestar Capital Partners is a leading U.S. middle-market private equity firm specializing in management buyouts and growth capital investments. Vestar invests and collaborates with incumbent management teams and private owners to build long-term enterprise value, with a focus on Consumer, Healthcare, and Business Services & Industrial Products. Since its founding in 1988, Vestar funds have completed more than 80 investments in companies – as well as more than 200 add-on acquisitions – with a total value of approximately $50 billion. For more information, please visit www.vestarcapital.com.
Media Contact / Matt Longman / 214.620.4364 / firstname.lastname@example.org